Stem cell treatment for hepatitis B–related cirrhosis
Part of Digestive system, Infections clinical trials.
This early-stage trial tests umbilical cord “mesenchymal” stem cells in people with liver scarring (cirrhosis) that is caused by hepatitis B. It may help improve liver function and related complications, but it is mainly designed to check safety and how well the treatment works.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have liver cirrhosis due to hepatitis B infection
- Your liver disease is in the “decompensated” stage (Child-Pugh B)
- You must be able and willing to participate in the study
- You do not have liver cancer or any other cancer
- You do not have hepatitis C or HIV infections
- You are not pregnant or breastfeeding
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a treatment made from stem cells to see if it is safe and can help reduce scarring and improve liver function in people with liver cirrhosis. It focuses on patients with moderate liver disease (Child-Pugh Class B).
This trial tests an injection of stem cells from donated umbilical cords to see if it can help people with advanced liver scarring from hepatitis B. You may be able to join if standard treatments haven’t helped enough and you aren’t able to get a liver transplant.
This trial studies whether umbilical cord stem cells are safe for people with advanced (decompensated) hepatitis B cirrhosis. It mainly looks at safety and whether symptoms or quality of life improve after standard care has not helped enough.
This trial tests whether a type of stem cell therapy is safe for people with liver cirrhosis caused by alcohol, hepatitis B, or hepatitis C. It may help if your liver disease is controlled and you have moderate to severe cirrhosis.
This Phase 1 study tests a stem cell product to see if it is safe and how it affects people with worsening hepatitis B-related cirrhosis. It may help researchers understand whether the treatment could improve liver function in this stage of illness.
This trial tests umbilical-cord stem cells to see if they can improve outcomes in people with decompensated (worsening) cirrhosis. You may be considered if your liver disease is moderate to severe (MELD 15–30) and you do not have certain high-risk problems right now.
Hear when a new Liver Cirrhoses trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.